A lower starting dose, hence, reduces that risk significantly
The theoretical oncogenic risk is a significant unresolved safety question for any long-term human application
But there is a silent reality that accompanies that weekly dose of Semaglutide: your relationship with food is about to fundamentally change, whether you are ready for it or not
The study lasted 9 weeks, during which clinical signs associated with biotin deficiency and biochemical parameters, such as serum and tissue biotin levels (liver, kidney, brain, testes), and biotin-dependent enzyme activity of 3-methylcrotonyl CoA carboxylase (MCC), propionyl-CoA carboxylase (PCC), pyruvate carboxylase (PC) and acetyl-CoA carboxylase (ACC), and blood glucose levels, were evaluated